Clinical Trials Update: June 23, 2009

-- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com:

Conjunctivitis, Bacterial

If you have conjunctivitis, you may qualify for this study.

The research site is in Haverhill, Mass.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=805.

-----

Neuropathy

If you have diabetic peripheral neuropathic pain, you may qualify for this study.

The research site is in Salt Lake City, Utah.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=215.

-----

Bladder Disorders

If you are at least 50 and have frequent nighttime urination, you may qualify for this study.

The research site is in Raleigh, N.C.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=445.

-----

High Blood Pressure (Hypertension)

This study is for adults who have high blood pressure, also known as hypertension.

The research site is in Gurnee, Ill.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/hypertension.aspx.

-----

Type 2 Diabetes and Weight Loss

People with type 2 diabetes who are overweight and have trouble controlling blood sugar with diet, exercise and/or oral medication may qualify this study of an investigational medication.

The research site is in Chicago, Ill.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.

-----

High Cholesterol

This study of an investigational medication is designed to help people improve high cholesterol, diabetes, and cardiovascular disease. Qualified participants will receive a physical exam, ECG, lab work and study medication at no cost.

The research site is in Atlanta, Ga.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/high_cholesterol.aspx.

-----

Copyright 2009 CenterWatch and ClinicalConnection.com. All rights reserved.

Posted: June 2009


View comments

Hide
(web3)